In preparation for a nuclear medicine exam, please wear comfortable clothes, follow instructions given to you by your physician, and be prepared for the exam to take several hours.
FDG - Do not eat or drink for eight hours prior to your test, with the exception of water or black coffee. Allow three hours for the exam.
NaF bone scan - Drink plenty of fluids. Expect the test to take two to three hours.
Axumin PET - Restage recurrent prostate cancer. Nothing to eat/drink four hours prior to test. Allow two hours for the exam.
PET myocardial viability - Do not eat four hours prior to the test, with the exception of water or black coffee. Allow four hours for the exam.
Detectnet Neuroendocrine scan - Requires discontinuing use of long acting somatostatin analogues for 28 days and discontinuing short acting statins for two days. Do not eat or drink for two hours prior to the test.
If you are unable to keep your appointment, please call 931-783-2222 to cancel your exam at least 24 hours prior to your appointment.
Do not eat or drink for six hours prior to study. The study will take up to four hours. Do not take any pain medication.
Drink plenty of fluids. Please come in at your scheduled time for the initial injection. You will need to return approximately three hours later for imaging. Expect the imaging part of the test to take about one hour.
There is no prep for this test. Expect the test to take about two hours.
Do not eat or drink for four hours prior to your appointment, and do not take any pain medications for six hours prior to the test. Expect the test to take two hours.
These procedures must be scheduled through Cookeville Regional Cancer Center.
Positron emission tomography, also called PET imaging or a PET scan, is a type of nuclear medicine imaging.
A non-invasive test, PET/CT accurately images metabolic information in the body, allowing physicians to diagnose problems, determine the extent of disease, prescribe treatment and track progress.
There is a new imaging technique for prostate cancer that locates cancer lesions using a PET-sensitive drug that has been FDA approved.
This is called F-18 Piflufolastate (Pylarify). This agent is used to detect tumors in the prostate, lymph nodes, bones and other organs.
This agent uses a Prostate Specific Membrane Antigen that is highly sensitive and specific for detecting prostate cancer. It has been approved for use in men who fall into the high or very high risk category for prostate cancer, as determined by their physician. It is also approved for use in men who have suspected recurrent prostate cancer after treatment.
This agent attaches to the Prostate Specific Membrane Antigen, a protein that is found on more than 90 percent of prostate cancer cells.
This entire exam requires approximately three hours to complete, but only a short scan time of 20-30 minutes.